Abstract

Heat shock response (HSR) is an essential host-defense mechanism that is dysregulated in obesity-induced insulin resistance and type 2 diabetes (T2D). Our recent data demonstrated that DNAJB3 was downregulated in obese human subjects and showed negative correlation with inflammatory markers. Nevertheless, DNAJB3 expression pattern in diabetic subjects and its mode of action are not yet known. In this study, we showed reduction in DNAJB3 transcript and protein levels in PBMC and subcutaneous adipose tissue of obese T2D compared to obese non-diabetic subjects. Overexpression of DNAJB3 in HEK293 and 3T3-L1 cells reduced JNK, IRS-1 Ser-307 phosphorylation and enhanced Tyr-612 phosphorylation suggesting an improvement in IRS-1 signaling. Furthermore, DNAJB3 mediated the PI3K/AKT pathway activation through increasing AKT and AS160 phosphorylation. AS160 mediates the mobilization of GLUT4 transporter to the cell membrane and thereby improves glucose uptake. Using pre-adipocytes cells we showed that DNAJB3 overexpression caused a significant increase in the glucose uptake, possibly through its phosphorylation of AS160. In summary, our results shed the light on the possible role of DNAJB3 in improving insulin sensitivity and glucose uptake through JNK repression and suggest that DNAJB3 could be a potential target for therapeutic treatment of obesity-induced insulin resistance.

Highlights

  • Heat shock response (HSR) is an essential host-defense mechanism that is dysregulated in obesityinduced insulin resistance and type 2 diabetes (T2D)

  • Our earlier report has shown a significant reduction in DNAJB3 transcripts from peripheral blood mononuclear cells (PBMCs) and adipose tissue of obese non-diabetics subjects compared to the lean controls (24)

  • We further looked at the expression level of DNAJB3 to include obese-T2D subjects

Read more

Summary

Introduction

Heat shock response (HSR) is an essential host-defense mechanism that is dysregulated in obesityinduced insulin resistance and type 2 diabetes (T2D). Our results shed the light on the possible role of DNAJB3 in improving insulin sensitivity and glucose uptake through JNK repression and suggest that DNAJB3 could be a potential target for therapeutic treatment of obesity-induced insulin resistance. JNK has been implicated in the mechanism of obesity-induced insulin resistance; germ-line ablation of JNK prevents both diet-induced obesity and insulin resistance 21–23 Taken together, these data highlight the importance of the HSPs cellular response in mitigating damages associated with obesity-mediated insulin resistance. Our recent data demonstrated that DNAJB3, an HSP-40 protein family member, is downregulated in response to obesity in peripheral blood mononuclear cells (PBMCs) and subcutaneous adipose tissue and showed negative correlation with key pro-inflammatory markers such as IP-10 and RANTES24. DNAJB3 expression pattern in diabetic subject and its mode of action are yet to be discovered

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call